Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...

During the training and sensitisation programme on emerging vector-borne diseases on Saturday, officials discussed the use of ...

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Combat-proven ISR platform will inform future Medium Range Reconnaissance (MRR) program MOORPARK, Calif., April 15, 2026 /PRNewswire/ -- Quantum-Systems Inc., a leader in unmanned intelligence and ...

Health experts warn that warmer temperatures and increased host populations could lead to higher disease transmission rates.

OpenSearch Software Foundation Executive Director Bianca Lewis and Governing Board Chair Carl Meadows on why the new ...

Tick season is off to an early and intense start across the U.S., with unusually high numbers of bites already reported.

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

Zilliz, the creator of Milvus -- the world's most widely adopted open-source vector database with over 43,000 GitHub stars and more than 10,000 enterprise deployments -- has been recognized as a ...

The U.S. Army has awarded a $15.3 million contract to German company Quantum Systems for the supply of Vector AI drones to ...